Title : p53 in human embryonal carcinoma: identification of a transferable, transcriptional repression domain in the N-terminal region of p53.

Pub. Date : 2005 Feb 24

PMID : 15674351






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We have previously shown that p53 repression in TGCT-derived human embryonal carcinoma (EC) is relieved upon treatment with all-trans retinoic acid (RA), resulting in enhanced p53 transactivation activity. Tretinoin tumor protein p53 Homo sapiens
2 We have previously shown that p53 repression in TGCT-derived human embryonal carcinoma (EC) is relieved upon treatment with all-trans retinoic acid (RA), resulting in enhanced p53 transactivation activity. Tretinoin tumor protein p53 Homo sapiens
3 We have previously shown that p53 repression in TGCT-derived human embryonal carcinoma (EC) is relieved upon treatment with all-trans retinoic acid (RA), resulting in enhanced p53 transactivation activity. Tretinoin tumor protein p53 Homo sapiens
4 We have previously shown that p53 repression in TGCT-derived human embryonal carcinoma (EC) is relieved upon treatment with all-trans retinoic acid (RA), resulting in enhanced p53 transactivation activity. Tretinoin tumor protein p53 Homo sapiens
5 While RA alone had no effect on p53-NRD activity, cotreatment with RA and the histone deacetylase inhibitor trichostatin-A (TSA) completely relieved p53-NRD-mediated repression. Tretinoin tumor protein p53 Homo sapiens